Scientists have confirmed the cannabis ingredient cannabinol (CBN) can increase sleep in rats, highlighting a new path for ...

Seasonal Affective Disorder (SAD) affects millions of Americans, and cases usually start to rise in late fall or early winter ...

Patients with non-seasonal depression who were treated with bright light therapy reported a 40% remission rate, according to a recent study.

31, 2024 — Sleep apnea, a common yet underdiagnosed sleep disorder, contributes to the development of dementia among adults -- particularly women, a new study suggests. At every age level ...

Fezolinetant, a nonhormonal agent, antagonizes neurokinin-3 receptors to treat moderate to severe VMS. Elinzanetant targets ...

A new clinical practice guideline provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes ...

The American Academy of Sleep Medicine updated its guidelines on the treatment of restless leg syndrome and periodic limb ...

According to the World Health Organization estimates, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year. Even though diabetes can ...

Sosei Group (JP:4565) has released an update. Nxera Pharma has received a $3.5 million milestone payment from Centessa Pharmaceuticals following the initiation of a Phase 2 trial for ORX750, a ...